JG
ONC

Jefferies Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,000
Closed -$1.97M – 2142
2020
Q1 		$1.97M Buy
+16,000
New +$2.5M 0.02% 696
2019
Q3 		– Sell
-3,984
Closed -$529K – 3110
2019
Q2 		$494K Sell
3,984
-2,668
-40% -$339K ﹤0.01% 1677
2019
Q1 		$878K Sell
6,652
-3,300
-33% -$445K 0.01% 1328
2018
Q4 		$1.4M Buy
9,952
+3,851
+63% +$511K 0.01% 997
2018
Q3 		$1.05M Sell
6,101
-4,258
-41% -$716K 0.01% 1303
2018
Q2 		$1.59M Buy
+10,359
New +$1.85M 0.01% 1009
2018
Q1 		– Sell
-2,892
Closed -$283K – 2788
2017
Q4 		$283K Buy
+2,892
New +$265K ﹤0.01% 2042

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jefferies Group's ONC Position: Q2 2020 in Review

Jefferies Group sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 16,000 shares — an estimated $1.97M sold.

Jefferies Group first reported a position in ONC in Q4 2017 and held it in 7 quarters. The position peaked at $1.97M in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Jefferies Group reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 16,000 BeOne Medicines Ltd shares in Q2 2020, an estimated $1.97M.
  • Jefferies Group first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 7 quarters.
  • Jefferies Group's BeOne Medicines Ltd position peaked at $1.97M in Q1 2020.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.